Our mission is to transform cancer care with enhanced detection, classification, and monitoring for improved treatment success

Detect cancer early when it is treatable

A novel genome-wide sequencing technique by the founders of Methylomics, to construct genome-wide DNA methylation profiles of normal and diseased tissue types 

A proprietary Multiplex qPCR assay for the detection of cervical AND all other anogenital cancer​ with a superior sensitivity and specificity

An atlas for improved diagnosis, classification and monitoring of cancer from blood

error: Content is protected !!